Neurologic Wilson's disease

被引:211
作者
Lorincz, Matthew T. [1 ]
机构
[1] Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48109 USA
来源
YEAR IN NEUROLOGY 2 | 2010年 / 1184卷
关键词
ceruloplasmin; copper; dysarthria; dystonia; tremor; Parkinsonism; movement disorders; LONG-TERM TREATMENT; HEPATOLENTICULAR DEGENERATION; ZINC THERAPY; AMMONIUM TETRATHIOMOLYBDATE; CLINICAL PRESENTATION; INITIAL THERAPY; FOLLOW-UP; LIVER-TRANSPLANTATION; PENICILLAMINE-THERAPY; PSYCHIATRIC-SYMPTOMS;
D O I
10.1111/j.1749-6632.2009.05109.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite a long history, Wilson's disease, an autosomal recessive disease caused by mutations in the ATP7B gene, remains a commonly misdiagnosed import disease. Mutations in ATP7B result in abnormal copper metabolism and subsequent toxic accumulation of copper. Clinical manifestations of neurologic Wilson's disease include variable combinations of dysarthria, dystonia, tremor, and choreoathetosis. Among neurodegenerative diseases, it is unusual in that misdiagnosis and delay in treatment are clinically relevant because treatments can prevent and cure Wilson's disease, if they are given appropriately. If left untreated, Wilson's disease progresses to hepatic failure or severe neurologic disability and death, while those adequately treated have normal life spans. This review focuses on the neurologic features of Wilson's disease, its diagnosis, and treatment options.
引用
收藏
页码:173 / 187
页数:15
相关论文
共 80 条
[41]   Neurological manifestations in Wilson's disease:: Report of 119 cases [J].
Machado, Alexandre ;
Chien, Hsin Fen ;
Deguti, Marta Mitiko ;
Cancado, Eduardo ;
Azevedo, Raymundo Soares ;
Scaff, Milberto ;
Barbosa, Egberto Reis .
MOVEMENT DISORDERS, 2006, 21 (12) :2192-2196
[42]   WILSONS-DISEASE - MRI WITH CLINICAL CORRELATION [J].
MAGALHAES, ACA ;
CARAMELLI, P ;
MENEZES, JR ;
LO, LS ;
BACHESCHI, LA ;
BARBOSA, ER ;
ROSEMBERG, LA ;
MAGALHAES, A .
NEURORADIOLOGY, 1994, 36 (02) :97-100
[43]   Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: A single-hospital, 10-year follow-up study [J].
Marcellini, M ;
Di Ciommo, V ;
Callea, F ;
Devito, R ;
Comparcola, D ;
Sartorelli, MR ;
Carelli, F ;
Nobili, V .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2005, 145 (03) :139-143
[44]   Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study [J].
Merle, U. ;
Schaefer, M. ;
Ferenci, P. ;
Stremmel, W. .
GUT, 2007, 56 (01) :115-120
[45]   WILSONS-DISEASE - CLINICAL PRESENTATION AND USE OF PROGNOSTIC INDEX [J].
NAZER, H ;
EDE, RJ ;
MOWAT, AP ;
WILLIAMS, R .
GUT, 1986, 27 (11) :1377-1381
[46]  
ODER W, 1991, J NEUROL, V238, P281
[47]   STUDIES ON HEPATOCEREBRAL DISEASE .3. HEPATOLENTICULAR DEGENERATION IN JAPAN, WITH STUDIES ON COPPER METABOLISM [J].
OKINAKA, S ;
TERAO, T ;
WATANABE, H ;
IGATA, A ;
KAMEYAMA, M ;
UONO, M ;
MURO, T ;
TOYOKURA, Y ;
MOZAI, T ;
OGIWARA, K ;
TSUBAKI, T ;
YOSHIKAWA, M ;
TANABE, H ;
UEDA, T .
NEUROLOGY, 1961, 11 (09) :792-&
[48]  
OSBORN SB, 1963, CLIN SCI, V24, P13
[49]   Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States [J].
Ostapowicz, G ;
Fontana, RJ ;
Schiodt, FV ;
Larson, A ;
Davern, TJ ;
Han, SHB ;
McCashland, TM ;
Shakil, AO ;
Hay, JE ;
Hynan, L ;
Crippin, JS ;
Blei, AT ;
Samuel, G ;
Reisch, J ;
Lee, WM .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (12) :947-954
[50]   Prognostic factors in patients presenting with severe neurological forms of Wilson's disease [J].
Prashanth, LK ;
Taly, AB ;
Sinha, S ;
Ravishankar, S ;
Arunodaya, GR ;
Vasudev, MK ;
Swamy, HS .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2005, 98 (08) :557-563